Dental Syringes Market Key Players, Share, Trend, Segmentation, and Forecast

Factors driving the growth of this market include increasing geriatric population, ongoing technological advancements in the field of dental syringes, and supportive government legislations to avoid needlestick injuries. However, the dearth of skilled dental surgeons is expected to limit the optimal growth of this market during the coming years.

According to the new market research report "Dental Syringes Market by Product (Non-disposable Syringes, Disposable Syringes and Safety Syringes), Type (Aspirating & Non-aspirating), Material (Plastic and Metallic), Region (North America, Europe , Asia-Pacific, and RoW) - Forecast", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

Revenue Growth Analysis:

The Global Dental Syringes Market is expected to reach USD 126.9 Million, at a CAGR of 5.2%

Download PDF Brochure (Please provide your specific interest in this report so as to help you better): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=42523876

In Detailed Market Segmentation:

On the basis of product, the market is categorized into three segments, namely, non-disposable syringes, disposable syringes, and safety syringes. The non-disposable syringes segment is expected to dominate the Dental Syringes Market, mainly due to the growing number of endodontic & periodontic procedures across the globe, significant adoption of non-disposable syringes among dental professionals for administering anesthesia, and greater affordability of these products due to their reusable nature.

Based on type, the market is segmented into two segments, namely, aspirating syringes, and non-aspirating syringes. The aspirating syringes segment is expected to dominate the market during the forecast period. The prominent market position of the aspirating syringes segment can be primarily attributed to the procedural benefits offered by aspirating syringes over conventional syringes (such as easy syringe handling, minimal operational stress, and better operational control), and longer shelf life of metallic syringes (as compared to conventional plastic syringes).

On the basis of material, the market is segmented into metallic and plastic-based dental syringes. Metallic syringes are expected to dominate the Dental Syringes Market during the study period owing to their advantages (such as long shelf life, reusability, and nonreactive nature) and significant adoption of metallic syringes among dentists.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=42523876

Geographical Segmentation and Opportunities:

Emerging markets (such as India, China, Brazil, and Mexico) offer significant growth opportunities for players operating in the dental syringes market. The growth of the market in these regions can be attributed to factors such as rising geriatric population, rising awareness among healthcare professionals related to needlestick injuries, and ongoing government initiatives to modernize & expand healthcare infrastructure.

The market is segmented into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World.

The Asia-Pacific market is expected to grow at the highest CAGR during the forecast period. The growth opportunities in the Asia-Pacific region can be attributed to the presence of a large patient population for target diseases (coupled with rapidly growing geriatric population, especially in Japan and China), rising awareness among healthcare professionals related to needlestick injuries, ongoing government initiatives to modernize & expand healthcare infrastructure, and continuous reduction in product prices.

Major Key Players in Worldwide Market:

Septodont (U.S.), 3M Company (U.S.), Dentsply International, Inc. (U.S.), Integra LifeSciences Corporation (U.S.), Vista Dental Products (U.S.), Power Dental USA, Inc. (U.S.), 4tek S.r.l (Italy), A. Titan Instrument Inc. (U.S.), and Delmaks Surgico (Pakistan) were some of the key players operating in the dental syringes market.

Veterinary X-ray Market 2019, Trend, Geographical Segmentation, Forecast

Rising animal health expenditure and growing demand for pet insurance, increasing number of veterinary practitioners in developed regions, and growth in the companion animals’ market are the primary drivers for the veterinary X-ray market during the forecast period.

What the Market Looks Like?

Predicted to grow at a CAGR of 6.4% during the forecast period, the global Veterinary X-ray Market is estimated to reach USD 872 million by the end of 2023.

On the basis of technology, the market is segmented into direct radiography (DR), computed radiography (CR), and film-based radiography systems. The computed radiography systems segment accounted for the largest share of the market in 2017. Benefits offered by CR systems over traditional X-ray systems, resulting in a large-scale replacement of traditional film X-ray systems, is the major factor responsible for the large share of this segment.

Based on the type of animal, the veterinary X-ray market is segmented into small companion animals and large animals. The small companion animals segment accounted for the largest share of the market in 2017. The large share of this segment can be attributed to the growing companion animal population, increasing pet care expenditure, growing demand for pet insurance, and technological advancements in imaging modalities for small companion animals.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=126397675

What Drives the Market?

The growth of the global market for Veterinary X-ray is primarily influenced by the following factors:

·         Growth in Companion Animal Population

·         Rising Demand for Pet Insurance with Growing Animal Health Expenditure

·         Growth in the Number of Veterinary Practitioners and Income Levels in Developed Economies

Geographical growth scenario of Veterinary X-ray Market

North America accounted for the largest share of the market in 2017, followed by Europe and the Asia Pacific. Rising number of veterinary practices, increasing number of companion animals, and rising companion animal healthcare expenditure are some of the key factors driving the growth of the market in North America.

 Leading market players and strategies adopted

The prominent players in the Veterinary X-ray market include IDEXX (US), Fujifilm (Japan), Onex Corporation (Canada), Sedecal (Spain), Agfa-Gevaert (Belgium), Sound Technologies (US), Fujifilm Holdings Corporation (Japan), Canon, Inc (Japan), Examion (Germany), Konica Minolta (US), DRE Veterinary (US), and Heska Corporation (US).

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=126397675

Onex Corporation is the leading player in the market. The company provides imaging systems through its subsidiary Carestream Health. Onex focuses on organic and inorganic growth strategies to strengthen its product portfolio. For instance, in 2015, the company launched the Vita Flex CR X-ray system for companion and livestock animals to cater to the specific needs of the veterinary X-ray market.

Additive Manufacturing Market size, Industry Analysis and Forecast

Additive manufacturing (AM) is an automatic process used to create rapid prototypes and functional end-use parts. It takes virtual designs from Computer Aided Design (CAD) software, and transforms them into thin, virtual, horizontal layer-wise cross-sections, until the model is complete. Various synonyms generally used for AM are additive fabrication, additive processes, additive techniques, additive layer manufacturing, layer manufacturing, and freeform fabrication.

The Additive Manufacturing Market is expected to grow at a CAGR of 13.5% to reach $3,471.9 million.

According to the American Society for Testing and Materials (ASTM), is the “process of joining materials to make objects from 3D model data, usually layer upon layer”. Various synonyms generally used for AM are additive fabrication, additive processes, additive techniques, additive layer manufacturing, layer manufacturing, and freeform fabrication.

Technological innovations in 3d printing have been witnessed over the past few years. Newer surgical products manufactured from AM, with better safety and efficacy attributes, contribute to the widespread adoption of the additive manufacturing in medical by physicians and patients worldwide.

Download PDF - Additive Manufacturing Market:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=843

Global 3D Printing Market, by industry

·         Automotives

·         Consumer products

·         Business machines

·         Medical

·         Academic

·         Aerospace

·         Government/military

Automotive or motor vehicles account for the largest share in this market, primarily due to the easy applications of 3D printing in the production of end-products (engines, spare parts, other interior, and exterior parts) as compared to other segments such as consumer products and business machines, which have limited usage in manufacturing of end-products. Rising healthcare expenditure in emerging economies provide growth opportunities for the AM technologies, as new healthcare facilities have come up in these areas.

New and improved technologies, financial support from governments, large application area, rapid product development at a low cost, and ease of development of custom products are the major drivers that are slated to propel additive manufacturing market. However, a few pivotal factors restraining the growth of this market are regulatory hurdles in different countries, material characterization during development, and process control and understanding.

The penetration rate of additive manufacturing for the medical devices market is faltering in emerging markets. However, established companies and new entrants in the additive manufacturing for medical devices market should consider these GDP growth rates, ease of product approval, increasing procedural volumes, and low penetration rates compared to mature markets, as the driving opportunistic factors that will plant the seed for future possible success for such companies.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=843

Geographical Analysis of Additive Manufacturing Market:

Europe accounts for the largest market share of the global additive manufacturing for medical devices market, followed by North America. In the future, it is estimated that the share of the European region will decrease, attributable to lowering device prices, regulatory pressures, and increasing focus of players towards emerging markets in the Asian and Latin American regions.

Major Key Players in Additive Manufacturing Market:

The key players in this market are 3D Systems Corporation (U.S.), 3T RPD (U.K.), Arcam AB (Sweden), Biomedical Modeling, Inc. (U.S.), Envisiontec GmbH (Germany), EOS GmbH Electro Optical Systems (Germany), Fcubic AB (Sweden), GPI Prototype and Manufacturing Services, Inc. (U.S.), Greatbatch, Inc. (U.S.), Layerwise NV (Belgium), Limacorporate SPA (Italy), Materialise NV (Belgium), Medical Modeling, Inc. (U.S.), and others.

Bone Growth Stimulator Market Key Players, Share, Trend, Segmentation and Forecast

[153 Pages Report] The Global Bone Growth Stimulator Market is estimated to reach USD 1.41 billion by 2022 from 1.03 billion at a CAGR of 5.4% during the forecast period.

Hospitals and Clinics Form the Fastest Growing End User Segment of the market.

Home care end users segment include patients who use external bone growth stimulator market; based on a physician’s prescription. Physicians recommend these stimulators to patients who have undergone spinal fusion surgery or are suffering from bone fractures that have failed to heal in the normal period of time (delayed or nonunion fracture). This segment is expected to witness growth due to rising physician preference for bone growth stimulators over their counterparts, cost-effectiveness of external stimulators in the case of nonunion fractures, government recommendations for the use of external stimulators, and the availability of reimbursement and insurance coverage.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82341383

key players in the Bone Growth Stimulator Market:

Orthofix International N.V. (U.S.), Medtronic plc (Ireland), Zimmer Biomet Holdings, Inc. (U.S.), DJO Finance LLC (U.S.), Bioventus LLC (U.S.), Stryker Corporation (U.S.), DePuy Synthes (U.S.), Arthrex, Inc. (U.S.), Isto Biologics (U.S.), and Harvest Technologies Corporation (U.S.) are some of the players operating the market.

Major Market Developments in Market:

# Orthofix International N.V. received CE and FDA approval for its next-generation bone growth stimulators, namely, Cervical-Stim and Spinal- Stim. These devices are used to stimulate and enhance natural healing process of the body post spinal fusion operation.

# Zimmer Holdings merged with Biomet, Inc., a U.S.-based company engaged in the development of musculoskeletal medical products. This merger helped both companies to expand their footprints in the global musculoskeletal devices market and strengthen its position in the Bone Growth Stimulators Market.

# Bioventus LLC, launched its Ultrasound Bone Healing System, EXOGEN in Saudi Arabia. The product is used in the treatment of delayed unions, non-unions, and joint fusion

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=82341383

Geographical Growth Analysis in Detailed:

The Bone Growth Stimulator Market is dominated by North America, followed by Europe, Asia, and the Rest of the World. North America is expected to dominate the market in 2016. Asia is expected to grow at a highest CAGR during the forecast period. Factors such as large population base, improving healthcare infrastructure and the rising prevalence of obesity and spinal disorders are key factors driving market growth in the Asia-Pacific region.

Molecular Cytogenetics Market Professional Survey Report 2019

The high prevalence of infectious diseases and various types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market, and advancements in molecular techniques are some of the key factors driving the growth of this market.

What the Market Looks Like?

Predicted to grow at a CAGR of 8.4% during the forecast period, the Global Molecular Diagnostics Market is estimated to reach USD 11.54 Billion by the end of 2023. In 2018, North America to dominate the market.

On the basis of technology, the market is broadly segmented into PCR, INAAT, DNA sequencing & NGS, in situ hybridization, DNA microarrays, and other technologies. The PCR segment is expected to account for the largest share of the global molecular diagnostics market in 2019. The large share of this segment is attributed to the growing use of PCR in proteomics and genomics, automation of PCR instruments, and the emergence of advanced technologies like qRT-PCR.

On the basis application, the market is broadly segmented into infectious diseases, oncology, genetic tests, and other applications. The infectious diseases segment is expected to account for the largest share of the global molecular diagnostics market in 2019. The large share of this segment is attributed to the development of advanced assays for different diseases and conditions, significant increase in the prevalence of infectious diseases, and rising awareness about the effective use of molecular diagnostic technologies to control the occurrence and spread of infectious diseases.

On the basis of end user, the Molecular Diagnostics Market is broadly segmented into hospitals and academic laboratories, reference laboratories, and other end users. The hospitals and academic laboratories segment is expected to account for the largest share of the market in 2019. The large share of this segment can primarily be attributed to the large number of diagnostic tests conducted in hospitals.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=833

What Drives the Market?

The growth of the global market for Molecular Diagnostics is primarily influenced by the following factors:

·         High Prevalence of Infectious Diseases and Various Types of Cancers

·         Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics

·         Growth in the Biomarker Identification Market and Advancements in Molecular Techniques

Geographical growth scenario of Molecular Diagnostics Market:

North America is expected to account for the largest share of the global market. The large share of this region is mainly attributed to the high prevalence of infectious diseases and cancers, presence of a highly developed healthcare system and large number of leading national clinical laboratories, easy accessibility to technologically advanced instruments in the region, availability of government funds, and growing applications of molecular diagnostics in genetic disorders and cancer screening.

Leading market players and strategies adopted:

The key players in the Global Molecular Diagnostics Market are Roche (Switzerland), Hologic (US), QIAGEN (Netherlands), Abbott (US), and Danaher (US).

These players focus on inorganic strategies such as acquisitions, partnerships, agreements, and collaborations as well as organic strategies such as expansions and product launches & approvals to sustain their positions in the market.

Read More in Detailed: https://www.marketsandmarkets.com/PressReleases/molecular-diagnostic.asp

Single-cell Analysis Market 2019 Precise Outlook - Merck KGaA (Germany), Becton, Dickinson and Company (U.S.)

The Single-cell Analysis Market, by cell type, is segmented into human, animal, and microbial cells. the human cells segment is expected to account for the largest share of the market. The growing application areas of human stem cells and the rising incidence of diseases such as cancer are the major factors driving the growth of this segment.

Technological advancements in single-cell analysis products, increasing government funding for cell-based research, growing biotechnology and biopharmaceutical industries, wide applications of single-cell analysis in cancer research, growing focus on personalized medicine, and increasing incidence and prevalence of chronic and infectious diseases are the major factors driving the growth of the market.

The objectives of this study are as follows:

• To define, describe, and forecast the market on the basis of products, cell type, technique, application, end user, and region.
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
• To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of market segments with respect to four regions, namely, North America, Europe, Asia, and the Rest of the World (RoW)

Speak to our analyst and gain crucial industry insights that will help your business grow:

https://www.marketsandmarkets.com/speaktoanalyst.asp?id=171955254

Browse and in-depth TOC on “Single-cell Analysis Market”.

107 — Tables

42 — Figures

175 — Pages

Single-cell Analysis Market, By Technique

• Flow Cytometry
• NGS
• PCR
• Microscopy
• Mass Spectrometry

Request for Free Sample Report @

https://www.marketsandmarkets.com/requestsample.asp?id=171955254

Single-cell Analysis Market, By Region:

• North America
• Europe
• Asia
• Rest of the World (RoW)

The Single-cell Analysis Market is highly fragmented in nature with several big as well as emerging players. Prominent players in this market include Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Promega Corporation (U.S.), Danaher Corporation (U.S.), General Electric Company (U.K.), Thermo Fisher Scientific Inc. (U.S.), Miltenyi Biotec (Germany), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Fluidigm Corporation (U.S.), NanoString Technologies, Inc. (U.S.), and Agilent Technologies (U.S.).

Cold Pain Therapy Market Research, In-Depth Analysis, Key Players, Applications, Forecast 2023

According to the new market research report "Cold Pain Therapy Market by Product (OTC (Gels, Sprays, Patches, Cold Packs, Wraps, Pads, and Roll-Ons), Prescription-Based (Motorized, Non-Motorized Devices), Applications (Musculoskeletal Disorders, Post-Operative Therapy, Sports Medicine, and Post-Trauma Therapy) - Global Forecast to 2023", published by MarketsandMarkets™, the Global Cold Pain Therapy Market is projected to reach USD 2.12 Billion by 2023 from USD 1.69 Billion in 2018, at a CAGR of 4.6% during the forecast period.

Factors such as the increasing incidence of sports injuries and a rising emphasis on exercise, the growing number of hip and knee surgeries across the globe, and a rising need for safer pain management modalities (as compared to oral therapy) are expected to drive the demand for cold pain therapy during the study period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=55543905

The OTC products segment is expected to register the highest growth rate during the forecast period

Based on product, the Cold Pain Therapy Market is divided into OTC products and prescription products. OTC products are expected to grow at the highest CAGR during the forecast period. The high patient preference for topical pharmaceuticals as compared to oral medications, owing to their lower side effects, fast pain relief, and convenience, is expected to drive the growth of the OTC products segment in the next five years.

Browse and in-depth TOC on "Cold Pain Therapy Market"

106 - Tables

126 - Figures

273 - Pages

Musculoskeletal disorders are estimated to form the largest segment of the market, by application

The Cold Pain Therapy Market is segmented, by application, into musculoskeletal disorders, post-operative therapy, sports medicine, and post-trauma therapy. The musculoskeletal disorders segment is expected to account for the largest share of the Cold Pain Therapy Market in 2018, owing to the increasing incidence of arthritis, osteoarthritis, back pain, and joint pain; increasing trend of self-care; and the growing preference for topical analgesics to manage musculoskeletal pain.

In 2017, North America accounted for the largest share of the Cold Pain Therapy Market

Geographically, the Cold Pain Therapy Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2017. The growing geriatric population, the high incidence of arthritis and sports injuries, product launches, the large number of surgeries, and stringent regulations on opioid prescription are expected to drive the growth of cold pain therapy products this region.

Read a Press-Release on “Cold Pain Therapy Market”:

https://www.marketsandmarkets.com/PressReleases/cold-pain-therapy.asp

As of 2017, the major players in the Cold Pain Therapy Market are Sanofi (France), DJO Finance (US), and Pfizer (US). Other players in this market include 3M (US), Hisamitsu Pharmaceutical (Japan), Johnson & Johnson (US), Medline Industries (US), Össur (Iceland), Performance Health (US), Beiersdorf (Germany) Rohto Pharmaceutical (US), Breg (US), Romsons Group of Industries (India), Custom Ice (US), and Unexo Life Sciences (India).

Humanized Mouse and Rat Model Market Growth and Analysis, Industry Trends, Size, Shares, Forecast to 2022

According to the new market research report "Humanized Mouse and Rat Model Market by Type (Genetic, Cell-Based (CD34, PBMC, BLT)), Application (Neuroscience, Hematopoesis, Oncology, Immunology & Infectious Diseases) & End User (Pharmaceutical & Biotechnology Companies, CRO)) - Global Forecast", published by MarketsandMarkets™, The humanized rat models market is expected to reach USD 8.9 Million, at a CAGR of 8.4% during the forecast period. The humanized mouse models market is projected to reach USD 128.9 Million, at a CAGR of 9.9% during the forecast period.

Growth in this market can primarily be attributed to factors such as the growing demand of personalized medicine, continuous support in the form of investments and grants from the government and private sectors, increasing number of R&D activities in pharmaceutical and biotechnology companies, and the increasing number of research activities involving humanized models. Increasing production of monoclonal antibodies and rising demand for humanized rat models are expected to provide a wide range of growth opportunities for players in the market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131763955

The oncology segment commanded the largest share of the humanized mouse models market.

By application, the humanized mouse models market is categorized into oncology, immunology and infectious diseases, neuroscience, hematopoiesis, toxicology, and other applications. Of all these application segments, oncology accounted for the largest share of the humanized mouse models market in 2017. The increasing research activities and growing funding from various governments to carry out research studies on cancer are the major factors driving the growth of this segment.

Browse and in-depth TOC on "Humanized Mouse and Rat Model Market"

94 - Tables

42 - Figures

189 - Pages

Cell-based humanized mouse models to grow at the highest CAGR during the forecast period

By type, the humanized mouse models market is categorized into genetic and cell-based humanized mouse models. The cell-based humanized mouse models segment is expected to grow at the highest CAGR during the study period (2017–2022). The high growth of this segment can be attributed to the growing applications of cell-based humanized mouse models.

The cell-based humanized mouse models segment is further categorized into CD34, PBMC, and BLT humanized mouse models. In 2017, the CD34 models segment commanded the largest share of the cell-based humanized mouse models market and is expected to grow at the highest CAGR during the forecast period.

Contract Research Organizations (CROs) to dominate the humanized mouse models market during the forecast period

By end user, the humanized mouse models market is categorized into pharmaceutical & biotechnology companies, contract research organizations (CRO), and academic & research institutions. The contract research organizations (CROs) segment is projected to grow at the highest CAGR during the forecast period. Growth in this segment is largely due to the increasing number of pharmaceutical companies outsourcing their preclinical studies to contract research organizations (CROs).

North America dominated the market in 2017

North America dominated the global humanized mouse models market in 2017. Growth in this regional segment can be attributed to the increasing monoclonal antibody production, preclinical activities by CROs and pharmaceutical R&D, continued and responsible use of animals ensured by animal care organizations, growing biomedical research in the US along with government support for the development of protein drugs, and growing stem cell research in Canada.

Read More About Humanized Mouse and Rat Model Market: https://www.marketsandmarkets.com/PressReleases/humanized-mouse-model.asp

The major market players in the humanized mouse models market include The Jackson Laboratory (US), Taconic Biosciences, Inc. (US), Horizon Discovery Group plc (UK), genOway, S.A. (France), Charles River Laboratories (US), Harbour Antibodies BV (China), Hera BioLabs (US), Vitalstar Biotechnology Co., Ltd. (China), inGenious Targeting Laboratory (US), AXENIS S.A.S (France), Crown Bioscience, Inc. (US), Transgenic, Inc. (Japan), and Champions Oncology, Inc. (US). The major players in the humanized rat models market include Horizon Discovery Group plc (UK), Hera BioLabs (US), and Yecuris Corporation (US).